Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of PMV Pharmaceuticals Inc (NASDAQ: PMVP) was $1.17 for the day, down -1.68% from the previous closing price of $1.19. In other words, the price has decreased by -$1.68 from its previous closing price. On the day, 0.52 million shares were traded. PMVP stock price reached its highest trading level at $1.23 during the session, while it also had its lowest trading level at $1.14.
Ratios:
Our analysis of PMVP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.76 and its Current Ratio is at 10.76. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On May 13, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $6.
On April 12, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $5.Jefferies initiated its Buy rating on April 12, 2024, with a $5 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 23 ’25 when ORBIMED ADVISORS LLC sold 1,000,000 shares for $1.52 per share. The transaction valued at 1,520,000 led to the insider holds 4,975,291 shares of the business.
OrbiMed Private Investments V, bought 1,000,000 shares of PMVP for $1,520,000 on Oct 23 ’25. On Sep 10 ’25, another insider, ORBIMED ADVISORS LLC, who serves as the 10% Owner of the company, sold 500,000 shares for $1.80 each. As a result, the insider received 900,000 and left with 5,975,291 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PMVP now has a Market Capitalization of 62257464 and an Enterprise Value of -64997308.
Stock Price History:
The Beta on a monthly basis for PMVP is 1.47, which has changed by -0.25625002 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, PMVP has reached a high of $1.84, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is -15.22%, while the 200-Day Moving Average is calculated to be -5.85%.
Shares Statistics:
PMVP traded an average of 1.18M shares per day over the past three months and 270530 shares per day over the past ten days. A total of 52.99M shares are outstanding, with a floating share count of 43.76M. Insiders hold about 17.75% of the company’s shares, while institutions hold 55.00% stake in the company. Shares short for PMVP as of 1763078400 were 1534893 with a Short Ratio of 1.30, compared to 1760486400 on 1526449. Therefore, it implies a Short% of Shares Outstanding of 1534893 and a Short% of Float of 3.4000000000000004.
Earnings Estimates
The company has 4.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.21 and low estimates of -$0.41.
Analysts are recommending an EPS of between -$1.51 and -$1.58 for the fiscal current year, implying an average EPS of -$1.54. EPS for the following year is -$1.43, with 4.0 analysts recommending between -$0.91 and -$1.65.
